glp-1 medications and anesthesia Are Serious Risks of Semaglutide Other Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia GLP-1 Medications | Daniel Stark

Others want nothing to do with needles, prescriptions, or the gastrointestinal side effects that come with pharmaceutical doses

Research news Danish register study presented at the European Congress on Obesity has associated glucagon-like peptide-1 receptor agonist treatment with a 26 per cent reduction in asthma exacerbations and lower use of reliever medication among adults with asthma and overweight, obesity or type 2 diabetes Novel research has linked the use of glucagon-like peptide-1 (GLP-1) receptor agonist drugs in people with asthma to a reduction in asthma exacerbations and a fall in the use of reliever inhalers

SPECIAL REPORT The Basics of GLP-1 Menu Innovation Understanding the flavor cravings of GLP-1 Guests This article is part of a two-part series exploring GLP-1s and their potential impact on foodservice

The FDA-approved titration schedule starts at a low dose (0.25 mg weekly for Ozempic or Wegovy) to minimize gastrointestinal side effects, gradually increasing every four weeks

Diabetes: Often long-term

Resources We Trust Cleveland Clinic: How Fast Do GLP-1 Drugs Suppress Appetite